Sagacious Research is a fast growing Intellectual Property Research and Patent Search firm based in India providing global and multi-lingual Patent Searches and in-depth Licensing Support. At Sagacious, specialized & dedicated techno-legal patent search experts work with Patent Practitioners, Inventors/Researchers, In-house Patent Cousels/Businesses, and Technology Investors throughout the Patent Lifecycle helping take informed decisions. Most important of our service offerings include global multi-lingual Prior-Art/ Patent Searches, Patent Licensing & Litigation Support, Patent Drafting Support, and Patent Watches/Monitoring.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y:
European Patent Office Abolishes Prior “Short” Divisional Guidelines Read: http://goo.gl/5T7bUF Canada & European Union to Soon Enter in a Free Trade Agreement ‘CETA’ Read: http://goo.gl/YNAIZA Single Trans-Tasman Patent Application & Examination Processes for Patents Approved in New Zealand Read: http://goo.gl/YUYHTb US Congress Introduces Bill for Patent Law Reform in US Read: http://goo.gl/8dxrdl
The biosimilar segment is fast growing (as per an estimate it will grow from $172 million in 2010 to an estimated $3.927 billion by 2017)
and if biopharma companies take initiatives in this direction, they can greatly benefit and boost their sales and growth despite of patent cliff
besides compensating for huge losses incurred upon them due to patent expirations of blockbuster biologic compounds by 2020 that
generated a combined sale of $67 billion for them.
Biosimilars are officially approved subsequent versions of a biological medicine
that has already been patented or authorized and are made by a different
sponsor following patent and exclusivity expiry. In US, FDA and in Europe,
European Medicines Agency (EMA) regulates the approval procedure for
biosimilars.
Conclusion
So basically, patent cliff isn’t that big an issue that it is perceived as. It is just a
transitory phase in the global business climate wherein the financial future of pharmaceutical companies will depend on how they manage
the transition of many of their brand drugs to the generic market and on their ability to develop novel therapeutics with significant profit
potential and finding alternatives like biosimilars.
Smartphone War- Nokia vs. Blackberry
Nokia Corporation has sued Blackberry for infringing its “WLAN patents”
One of the most prolific patent war happened between Nokia and Blackberry in 2012.
Finnish mobile giant accused Research in Motion for infringing WLAN patents that
enable the handsets to connect to wireless local access network or WiFi. Wi-Fi allows
cheaper deployment of local area networks (LANs) and thus, manufacturers are
building WLAN or wireless network adapters into most of the devices including
laptops and mobiles. If a smartphone is capable of using built-in Wi-Fi, it gives its
users the opportunity to connect easily from hotels, home, offices, book stores and
client sites. WLAN boosts business efficiency as research, invoicing, email and project
development can be handled without having to return to a desktop computer at the
main office.
S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y:
The 3 Best-Selling Drugs in the World: Read: http://goo.gl/wRH3aQ Myriad Sues GeneDx on BRCA & Other Genetic Diagnostic Patents Read: http://goo.gl/7Ywnml Are Patents Blocking Access to Life-Saving Drugs in India? Read: http://bit.ly/HcKID1 Eli Lilly’s Profit Soars as US Patents on Anti-depressent Drug “Cymbalta” Nears Expiration Read: http://goo.gl/KVMifb
would provide an audible sound when operated by a user to navigate between icons and other selectable items.
In another patent filing, company reveals a Storable Keyboard having variable angular orientations. A keyboard moves between a stored
position inside the housing and a deployed position just like a matchbox.
A few outstanding patent buy outs and deals that have been signed:
1. In the Nortel auction of July 2011, more than 6,000 patents from Nortel were auctioned for approx. $4.5 billion and BlackBerry
paid about $770 million for its share. Other potential bidders were Apple Inc., Google, Nokia etc.
2. Google paid $12.5 billion for Motorola Mobility, another former mobile-phone pioneer, primarily for a patent portfolio so that it
could use it as a safeguard against litigation involving its Android operating system.
3. Most recent Nokia Microsoft $7.2 billion deal shows that patents still have plenty of value, including their ability to create fresh
revenue. Nokia sold its handset business to Microsoft but kept control of its patents, which now generate more than 500 million
euros ($676 million) a year in licensing revenue.
It is much evident that BlackBerry has a rich patent portfolio. Thus, BlackBerry could drive its bidding price to as much as $5 billion.
Financial Holdings Ltd. has already offered a $4.7 billion buyout proposal to Blackberry but no official deal has been signed.
Negotiations with relevant bidders play a vital role in such a scenario, thus, seeking services from patent research service
providers who provide product-to-patent mapping services is a much thought over and calculated step. These services can help
potential buyers (and/or sellers) in evaluating and understanding what patented technology is behind the product and what all features of a
product can be attributed to its patent. Thus, strategic business decisions regarding segregating patent portfolio into patents with potential
for buying/selling and licensing can be formulated.
Conclusion
It is unlikely that Blackberry commands the same premium as Nortel or Motorola Mobility because market has changed. But it is certain
that if BlackBerry’s portfolio is properly analysed, it can make the company a very lucrative buy. Its licensable patents alone should be able
to earn on an average at least $100 million in licensing revenue annually.
T E C H N O L O G Y
S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y:
AMD, Altera, ADI Emerges Top 3 semiconductor Innovators: Says Patent Metric Read: http://goo.gl/Hc8Tva Twitter’s Dearth of Patents Could Hinder it Down the Road: Says Report Read: http://goo.gl/4v2eB8 ‘Steve Jobs Patent’ On Multitouch To Blow Off All Android Makers as USPTO Confirms All Its 20 Claims Read: http://goo.gl/YDdAfL Google Plans to Patent DJ’s Favorite Hand Gestures Read: http://goo.gl/dL6Yxu Neonode Wins US Patent for Flush (Bezel-free) Cover-Glass Design, With Potential to Replace Capacitive Touchscreens Read: http://goo.gl/pRrzsm